Radiolabeled antibodies in prostate cancer: A case study showing the effect of host immunity on antibody bio-distribution
- 23 December 2014
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 42 (4) , 375-380
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detectionThrombosis and Haemostasis, 2013
- Imaging Androgen Receptor Signaling with a Radiotracer Targeting Free Prostate-Specific AntigenCancer Discovery, 2012
- Kallikreins on Steroids: Structure, Function, and Hormonal Regulation of Prostate-Specific Antigen and the Extended Kallikrein LocusEndocrine Reviews, 2010
- Prostate-specific antigen and prostate cancer: prediction, detection and monitoringNature Reviews Cancer, 2008
- Improved tumor imaging and therapy via i.v. IgG–mediated time-sequential modulation of neonatal Fc receptorJournal of Clinical Investigation, 2007
- Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with ageThe Prostate, 2005
- Mechanisms of IVIG action in immune thrombocytopenic purpura.2004
- Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor.2002
- Capromab Pendetide Imaging of Prostate CancerCancer Biotherapy and Radiopharmaceuticals, 2000
- Enzymatic activity of prostate‐specific antigen and its reactions with extracellular serine proteinase inhibitorsEuropean Journal of Biochemistry, 1990